LPL Financial
ARQT icon

LPL Financial’s Arcutis Biotherapeutics ARQT Stock Holding History

LPL Financial’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.9M Sell
109,545
-1,605
-1% -$42K ﹤0.01% 3394
2026
Q2 		$2.91M Sell
111,150
-8,231
-7% -$192K ﹤0.01% 3327
2026
Q1 		$2.81M Buy
119,381
+7,507
+7% +$192K ﹤0.01% 3188
2025
Q4 		$3.25M Sell
111,874
-5,050
-4% -$129K ﹤0.01% 2930
2025
Q3 		$2.2M Sell
116,924
-4,693
-4% -$74K ﹤0.01% 3227
2025
Q2 		$1.71M Buy
121,617
+5,860
+5% +$82.2K ﹤0.01% 3275
2025
Q1 		$1.81M Sell
115,757
-5,135
-4% -$72.3K ﹤0.01% 3037
2024
Q4 		$1.68M Sell
120,892
-5,388
-4% -$59K ﹤0.01% 3027
2024
Q3 		$1.17M Sell
126,280
-23,260
-16% -$230K ﹤0.01% 3240
2024
Q2 		$1.39M Sell
149,540
-8,665
-5% -$78.4K ﹤0.01% 2943
2024
Q1 		$1.57M Sell
158,205
-31,438
-17% -$235K ﹤0.01% 2766
2023
Q4 		$613K Buy
189,643
+106,130
+127% +$289K ﹤0.01% 3505
2023
Q3 		$443K Buy
83,513
+48,931
+141% +$416K ﹤0.01% 3587
2023
Q2 		$330K Buy
+34,582
New +$384K ﹤0.01% 3770

Other funds holding ARQT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Jay A. Fishman Ltd
Jay A. Fishman Ltd Troy, Michigan $1.24B AUM 21.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

LPL Financial's ARQT Position: Q3 2026 in Review

LPL Financial reduced its Arcutis Biotherapeutics (ARQT) stake by 1.4% in Q3 2026, selling an estimated $42K and leaving 109,545 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

LPL Financial first reported a position in ARQT in Q2 2023 and has held it in 14 quarters since. The position peaked at $3.25M in Q4 2025. 112 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • LPL Financial held 109,545 shares of Arcutis Biotherapeutics worth $2.9M as of Q3 2026.
  • LPL Financial sold 1,605 Arcutis Biotherapeutics shares in Q3 2026, an estimated $42K.
  • Arcutis Biotherapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #3394 holding.
  • LPL Financial first reported a position in Arcutis Biotherapeutics in Q2 2023 and has held it in 14 quarters since.
  • LPL Financial's Arcutis Biotherapeutics position peaked at $3.25M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.